Sofosbuvir, pegylated interferon and ribavirin in treatment of an Egyptian cohort with hepatitis C virus infection in real life clinical practice
about
Sofosbuvir, pegylated interferon and ribavirin in treatment of an Egyptian cohort with hepatitis C virus infection in real life clinical practice
description
scientific article published on 01 January 2019
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Sofosbuvir, pegylated interfer ...... in real life clinical practice
@en
Sofosbuvir, pegylated interfer ...... in real life clinical practice
@nl
type
label
Sofosbuvir, pegylated interfer ...... in real life clinical practice
@en
Sofosbuvir, pegylated interfer ...... in real life clinical practice
@nl
prefLabel
Sofosbuvir, pegylated interfer ...... in real life clinical practice
@en
Sofosbuvir, pegylated interfer ...... in real life clinical practice
@nl
P2093
P1476
Sofosbuvir, Pegylated Interfer ...... in Real-Life Clinical Practice
@en
P2093
Abdelrahman Kobtan
Amal Selim
Loai Mansour
Mohamed Yousef
Nehad Hawash
Rehab Badawi
Reham A Elkhouly
Sally Elnawasany
Shaimaa Soliman
Sherief Abd-Elsalam
P304
P356
10.2174/1871526518666180912121835
P407
P50
P577
2019-01-01T00:00:00Z